Business Context and Reporting Period
This Form 6-K filing by Evogene Ltd. is dated June 14, 2018, covering the month of June 2018. The filing serves to notify shareholders of the upcoming Annual General Meeting scheduled for July 24, 2018, at the company's offices in Rehovot, Israel.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural notice regarding a shareholder meeting and does not contain financial statements or performance data.
Material Changes
No material financial changes versus the prior comparable period are reported in this filing, as no financial data is presented.
Guidance, Outlook, and Management Commentary
The filing contains no management commentary, financial guidance, outlook, risks, contingencies, or unusual items. It strictly lists the meeting details and references attached exhibits (Notice of Meeting, Proxy Statement, and Proxy Card) available on the company's investor relations website.
Key Facts for Investor Verification
- Annual General Meeting date: July 24, 2018.
- Meeting location: 13 Gad Feinstein Street, Park Rehovot, Rehovot, Israel.
- Meeting time: 3:00 p.m. Israel time.
- Key documents (Notice, Proxy Statement, Proxy Card) are filed as Exhibits 99.1, 99.2, and 99.3.
- Financial performance data is not included in this specific filing.